Best Vesicular Monoamine Transporter 2 Inhibitor for tardive dyskinesia
The 2 Vesicular Monoamine Transporter 2 Inhibitor options we list for tardive dyskinesia are all Valbenazine Tosylate— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for tardive dyskinesia or the full Vesicular Monoamine Transporter 2 Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 vesicular monoamine transporter 2 inhibitor drugs we rate for tardive dyskinesia, none are yet flagged as generics in our price data, and most are capsule. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for tardive dyskinesia; the right choice depends on your situation, so confirm it with your prescriber.
These are all Valbenazine Tosylatein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 vesicular monoamine transporter 2 inhibitor products
ingrezza
Boxed warningPrescriptionFDA-sourced
Ingrezza (Valbenazine Tosylate) is a vesicular monoamine transporter 2 inhibitor used to treat Tardive Dyskinesia.
Price varies
ingrezza sprinkle
Boxed warningPrescriptionFDA-sourced
Ingrezza Sprinkle (Valbenazine Tosylate) is a vesicular monoamine transporter 2 inhibitor used to treat Tardive Dyskinesia.
Price varies
Frequently asked
- What is the best vesicular monoamine transporter 2 inhibitor for tardive dyskinesia?
- The Vesicular Monoamine Transporter 2 Inhibitor options we list for tardive dyskinesia are all Valbenazine Tosylate — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which vesicular monoamine transporter 2 inhibitor drugs treat tardive dyskinesia?
- pharmaranks lists 2 Vesicular Monoamine Transporter 2 Inhibitor products used for tardive dyskinesia, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.